We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$740M
AUM Growth
+$30.5M
Cap. Flow
-$239M
Cap. Flow %
-32.31%
Top 10 Hldgs %
67%
Holding
218
New
56
Increased
59
Reduced
50
Closed
36

Top Buys

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$40.7M
2
SLAI
SOLAI Ltd ADS
SLAI
+$15.2M
3
VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
+$7.02M
4
FLUX icon
Flux Power
FLUX
+$6.05M
5
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.87M

Top Sells

Rank Stock Value
1
LNAI
Lunai Bioworks
LNAI
+$7.71M
2
ATOS icon
Atossa Therapeutics
ATOS
+$4.06M
3
ATER icon
Aterian
ATER
+$4M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$2.95M
5
RDHL
Redhill Biopharma
RDHL
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 6.89%
2 Financials 5.45%
3 Technology 3.65%
4 Industrials 1.84%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
1
PUT
iShares S&P 100 ETF
OEF
$19.8B
$39.2M 5.3%
1,794
+500
+39% +$102K
OEF icon
2
CALL
iShares S&P 100 ETF
OEF
$19.8B
$32.8M 4.44%
+1,500
New +$305K
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$32.2M 4.35%
+750
New +$331K
BTBT icon
4
Bit Digital
BTBT
$459M
$30.5M 4.12%
+4,216,310
New +$40.7M
XNTK icon
5
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$21.5M 2.91%
1,713
+429
+33% +$68.6K
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$19.1M 2.58%
444
+10
+2% +$4.41K
SRNE
7
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$16.7M 2.25%
21,846
+1,604
+8% +$13.6K
SLAI
8
DELISTED
SOLAI Ltd ADS
SLAI
$16.3M 2.21%
+28,571
New +$15.2M
VXX icon
9
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$14.8M 2.01%
334
+279
+507% +$125K
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$13M 1.75%
1,698,107
+500,131
+42% +$4.24M
VXX icon
11
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$11.1M 1.5%
25,000
+13,087
+110% +$5.87M
MARA icon
12
PUT
Marathon Digital Holdings
MARA
$4.34B
$6.27M 0.85%
1,985
+1,073
+118% +$34.9K
COCP icon
13
Cocrystal Pharma
COCP
$12.9M
$5.42M 0.73%
430,451
-78,770
-15% -$1.04M
ATOS icon
14
PUT
Atossa Therapeutics
ATOS
$24.1M
$5.13M 0.69%
1,048
-648
-38% -$37.7K
OCUL icon
15
CALL
Ocular Therapeutix
OCUL
$1.85B
$5.12M 0.69%
5,115
+3,447
+207% +$38.7K
CAN
16
PUT
Canaan Creative
CAN
$178M
$4.81M 0.65%
7,875
+4,133
+110% +$32.1K
VRPX
17
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$4.77M 0.64%
3,972
+3,353
+542% +$7.02M
RCAT icon
18
Red Cat Holdings
RCAT
$1.13B
$4.73M 0.64%
+1,359,385
New +$4.21M
TKAT
19
DELISTED
Takung Art Co., Ltd.
TKAT
$4.62M 0.62%
+608,740
New +$5.04M
KNDI
20
PUT
Kandi Technologies Group
KNDI
$63.5M
$4.33M 0.59%
9,742
+475
+5% +$2.4K
AMRN
21
CALL
Amarin Corp
AMRN
$293M
$4.2M 0.57%
412
+99
+32% +$9.73K
BTBT icon
22
PUT
Bit Digital
BTBT
$459M
$4.04M 0.55%
+5,586
New +$53.9K
HMCO
23
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$4M 0.54%
404,185
– –
BFLY icon
24
CALL
Butterfly Network
BFLY
$1.88B
$3.66M 0.49%
3,503
+1,093
+45% +$12.6K
FLUX icon
25
Flux Power
FLUX
$12.1M
$3.63M 0.49%
+715,211
New +$6.05M
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sabby Management held 218 positions worth $740M, up 4.3% from $709M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sabby Management withdrew a net $239M in Q3 2021, closing 36 positions and reducing 50 holdings. Its most notable exit was Atossa Therapeutics, an estimated $4.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.9% of assets, down from 10% a quarter earlier, followed by Financials and Technology.

Against the trend, Sabby Management opened a new position in Bit Digital worth $30.5M.

  • Sabby Management's largest Q3 2021 buy was Bit Digital: 4,216,310 shares worth $30.5M.
  • Sabby Management added most to Virpax Pharmaceuticals, Inc. Common Stock in Q3 2021, an estimated $7.02M increase.
  • Sabby Management's biggest Q3 2021 reduction was Lunai Bioworks, cutting an estimated $7.71M.
  • Sabby Management fully exited Atossa Therapeutics in Q3 2021, selling an estimated $4.06M.
  • Sabby Management's ten largest holdings make up 67% of its $740M portfolio in Q3 2021.
  • Sabby Management opened 56 new positions and closed 36 in Q3 2021.
  • Sabby Management's portfolio value rose 4.3% quarter-over-quarter to $740M.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.